Literature DB >> 11280797

Induction of ETS-1 and ETS-2 transcription factors is required for thyroid cell transformation.

F de Nigris1, T Mega, N Berger, M V Barone, M Santoro, G Viglietto, P Verde, A Fusco.   

Abstract

The proteins of the Ets family are transcription factors involved in signal transduction, cell cycle progression, and differentiation. In this study, we report that thyroid cell neoplastic transformation is associated with a dramatic increase in ETS transcriptional activity, which is dependent on the accumulation of Ets-1, Ets-2, and other Ets-related proteins. Inhibition of ETS transactivation activity by the Ets-dominant negative construct (Ets-Z) induced programmed cell death in human thyroid carcinoma cell lines but not in normal thyroid cells. Apoptotic cell death induced by Ets-Z was dependent on the reduction of c-MYC protein levels, because it was prevented by overexpression of c-myc. Taken together, these data indicate that the induction of Ets-1 and Ets-2 transcription factors plays a pivotal role in thyroid cell neoplastic transformation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11280797

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  16 in total

1.  ETS2 mediated tumor suppressive function and MET oncogene inhibition in human non-small cell lung cancer.

Authors:  Ignacio I Wistuba; Humam Kadara; Mohamed Kabbout; Melinda M Garcia; Junya Fujimoto; Diane D Liu; Denise Woods; Chi-Wan Chow; Gabriela Mendoza; Amin A Momin; Brian P James; Luisa Solis; Carmen Behrens; J Jack Lee
Journal:  Clin Cancer Res       Date:  2013-05-09       Impact factor: 12.531

2.  Triplex DNA-mediated downregulation of Ets2 expression results in growth inhibition and apoptosis in human prostate cancer cells.

Authors:  Giuseppina M Carbone; Sara Napoli; Alessandra Valentini; Franco Cavalli; Dennis K Watson; Carlo V Catapano
Journal:  Nucleic Acids Res       Date:  2004-08-16       Impact factor: 16.971

3.  Selective inhibition of transcription of the Ets2 gene in prostate cancer cells by a triplex-forming oligonucleotide.

Authors:  Giuseppina M Carbone; Eileen M McGuffie; Angela Collier; Carlo V Catapano
Journal:  Nucleic Acids Res       Date:  2003-02-01       Impact factor: 16.971

4.  ETS transcription factor ELF3 (ESE-1) is a cell cycle regulator in benign and malignant prostate.

Authors:  Leanne K Archer; Fiona M Frame; Hannah F Walker; Alastair P Droop; Georgina L K McDonald; Samuel Kucko; Daniel M Berney; Vincent M Mann; Matthew S Simms; Norman J Maitland
Journal:  FEBS Open Bio       Date:  2022-05-06       Impact factor: 2.792

5.  The ePHD protein SPBP interacts with TopBP1 and together they co-operate to stimulate Ets1-mediated transcription.

Authors:  Eva Sjøttem; Cecilie Rekdal; Gunbjørg Svineng; Sylvia Sagen Johnsen; Helle Klenow; Rebecca Dale Uglehus; Terje Johansen
Journal:  Nucleic Acids Res       Date:  2007-10-02       Impact factor: 16.971

6.  The ETS Inhibitor YK-4-279 Suppresses Thyroid Cancer Progression Independent of TERT Promoter Mutations.

Authors:  Junyu Xue; Shiyong Li; Peijie Shi; Mengke Chen; Shuang Yu; Shubin Hong; Yanbing Li; Rengyun Liu; Haipeng Xiao
Journal:  Front Oncol       Date:  2021-06-16       Impact factor: 6.244

7.  The level of Ets-1 protein is regulated by poly(ADP-ribose) polymerase-1 (PARP-1) in cancer cells to prevent DNA damage.

Authors:  Arnaud J Legrand; Souhaila Choul-Li; Corentin Spriet; Thierry Idziorek; Dorothée Vicogne; Hervé Drobecq; Françoise Dantzer; Vincent Villeret; Marc Aumercier
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

Review 8.  Endogenous retrovirus-K promoter: a landing strip for inflammatory transcription factors?

Authors:  Mamneet Manghera; Renée N Douville
Journal:  Retrovirology       Date:  2013-02-09       Impact factor: 4.602

9.  The function of APC/CCdh1 in cell cycle and beyond.

Authors:  Min Li; Pumin Zhang
Journal:  Cell Div       Date:  2009-01-19       Impact factor: 5.130

10.  MicroRNA 17-92 cluster mediates ETS1 and ETS2-dependent RAS-oncogenic transformation.

Authors:  Mohamed Kabbout; Duaa Dakhlallah; Sudarshana Sharma; Agnieszka Bronisz; Ruchika Srinivasan; Melissa Piper; Clay B Marsh; Michael C Ostrowski
Journal:  PLoS One       Date:  2014-06-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.